Related Experiment Video
Updated: May 10, 2026

A Protocol for Detecting and Scavenging Gas-phase Free Radicals in Mainstream Cigarette Smoke
Published on: January 2, 2012
Smokeless tobacco and cancer
Paolo Boffetta1, Stephen Hecht, Nigel Gray
1International Agency for Research on Cancer, Lyon, France. boffetta@iarc.fr
Smokeless tobacco use is common globally and linked to increased oral, esophageal, and pancreatic cancer risks. While risks vary geographically, smokeless tobacco carcinogenicity is supported by animal studies.
Area of Science:
- Oncology
- Toxicology
- Epidemiology
Background:
- Smokeless tobacco product consumption is prevalent worldwide, with rising usage in numerous regions.
- Epidemiological studies indicate a significant association between smokeless tobacco use and elevated risks of certain cancers, though findings vary geographically.
- Smokeless tobacco contains carcinogenic nitrosamines, necessitating robust exposure assessment for understanding cancer development.
Purpose of the Study:
- To evaluate the global epidemiological evidence on the association between smokeless tobacco use and cancer.
- To quantify the attributable risk of smokeless tobacco use for specific cancers in different populations.
- To review the toxicological data and biomarker evidence supporting the carcinogenicity of smokeless tobacco products.
Main Methods:
- Systematic review and meta-analysis of epidemiological studies on smokeless tobacco and cancer.
- Analysis of cancer statistics to determine the proportion attributable to smokeless tobacco in specific countries.
- Review of animal carcinogenicity studies and biomarker data for exposure assessment.
Main Results:
- Epidemiological data from the USA and Asia show a 2.6-fold increased risk of oral cancer, but this is not confirmed in Northern European studies.
- Northern European studies indicate increased risks for esophageal (1.6-fold) and pancreatic cancers (1.6-fold).
- In India and Sudan, over 50% of oral cancers are linked to smokeless tobacco; in Swedish men, 20% of esophageal and pancreatic cancers are attributed to it.
Conclusions:
- Smokeless tobacco use is associated with increased risks of oral, esophageal, and pancreatic cancers, with significant geographical variations.
- While cancer risks for smokeless tobacco users are likely lower than for smokers, they are higher than for non-tobacco users.
- Biomarker development aids in quantifying exposure and modeling carcinogenesis, supported by strong animal carcinogenicity data.
More Related Videos
09:25Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 11, 2015
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer Prevention
Some...
Cancer Prevention
Some...
Other Pulmonary Disorders
Statistical Methods for Analyzing Epidemiological Data
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...